VOBRAMITAMAB DUOCARMAZINE

UNII:	2ZK3D69DQJ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	VOBRAMITAMAB DUOCARMAZINE
GSRS Full Record:	2ZK3D69DQJ i

2490556-51-7
AEX4089DC1
ANTI-B7H3 ANTIBODY-DRUG CONJUGATE MGC018
Immunoglobulin G1 [de-447-lysine], anti-(human B7 homolog 3 protein)(human-Mus musculus monoclonal PRCA157 γ1-chain), disulfide with human-Mus musculus monoclonal PRCA157 κ-chain, dimer, thioether with N-[[2-[2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)ethoxy]ethoxy]carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[7-[[[(1S)-1-(chloromethyl)-2,3-dihydro-3-[[6-[(4-hydroxybenzoyl)amino]imidazo[1,2-a]pyridin-2-yl]carbonyl]-9-methyl-1H-benz[e]indol-5-yl]oxy]carbonyl]-12-hydroxy-4-methyl-3-oxo-2,10-dioxa-4,7-diazadodec-1-yl]phenyl]-L-ornithinamide
MGC-018
MGC018
VOBRAMITAMAB DUOCARMAZINE [USAN]
Vobramitamab Duocarmazine
Vobramitamab duocarmazine [WHO-DD]
vobramitamab duocarmazine [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VOBRAMITAMAB DUOCARMAZINE

Synonyms and Mappings

Resources